SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-013614
Filing Date
2021-03-05
Accepted
2021-03-05 09:00:39
Documents
17
Period of Report
2021-03-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea137036-8k_aikidopharm.htm 8-K 18837
2 INVESTOR PRESENTATION, DATED MARCH 2021 ea137036ex99-1_aikidopharm.htm EX-99.1 20791
3 GRAPHIC ex99-1_001.jpg GRAPHIC 62678
4 GRAPHIC ex99-1_002.jpg GRAPHIC 120946
5 GRAPHIC ex99-1_003.jpg GRAPHIC 138569
6 GRAPHIC ex99-1_004.jpg GRAPHIC 167764
7 GRAPHIC ex99-1_005.jpg GRAPHIC 149916
8 GRAPHIC ex99-1_006.jpg GRAPHIC 136336
9 GRAPHIC ex99-1_007.jpg GRAPHIC 185503
10 GRAPHIC ex99-1_008.jpg GRAPHIC 115928
11 GRAPHIC ex99-1_009.jpg GRAPHIC 164385
12 GRAPHIC ex99-1_010.jpg GRAPHIC 158676
13 GRAPHIC ex99-1_011.jpg GRAPHIC 146019
14 GRAPHIC ex99-1_012.jpg GRAPHIC 161590
15 GRAPHIC ex99-1_013.jpg GRAPHIC 106514
16 GRAPHIC ex99-1_014.jpg GRAPHIC 160789
17 GRAPHIC ex99-1_015.jpg GRAPHIC 54726
  Complete submission text file 0001213900-21-013614.txt   2838765
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 21716682
SIC: 8731 Services-Commercial Physical & Biological Research